The pharmaceutical landscape is experiencing a change with the arrival of GLP-1 transdermal systems . These exciting formulations offer a potential alternative to administering glucagon-like peptide-1 https://kalebeex645641.timeblog.net/76830707/glp-1-patches-a-revolutionary-way-to-treat-diabetes